Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Multiple introductions of Mycobacterium tuberculosis lineage 2-Beijing into Africa over centuries
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4506993
Author(s) Rutaihwa L, Menardo F.; Stucki D, Gygli S. M.; Ley SD, Malla B.; Feldmann J, Borrell S.; Beisel C, Middelkoop K.; Carter JE, Diero L.; Ballif M, Jugheli L.; Reither K, Fenner L.; Brites D, Gagneux S.
Author(s) at UniBasel Rutaihwa, Liliana
Menardo, Fabrizio
Stucki, David
Gygli, Sebastian
Ley, Serej
Feldmann, Julia
Borrell Farnov, Sonia
Jugheli, Levan
Reither, Klaus
Fenner, Lukas
Brites, Daniela
Gagneux, Sebastien
Year 2019
Title Multiple introductions of Mycobacterium tuberculosis lineage 2-Beijing into Africa over centuries
Journal Frontiers in Ecology and Evolution
Volume 7
Pages / Article-Number 112
Abstract The Lineage 2–Beijing (L2–Beijing) sub-lineage of Mycobacterium tuberculosis has received much attention due to its high virulence, fast disease progression, and association with antibiotic resistance. Despite several reports of the recent emergence of L2–Beijing in Africa, no study has investigated the evolutionary history of this sub-lineage on the continent. In this study, we used whole genome sequences of 781 L2 clinical strains from 14 geographical regions globally distributed to investigate the origins and onward spread of this lineage in Africa. Our results reveal multiple introductions of L2–Beijing into Africa linked to independent bacterial populations from East- and Southeast Asia. Bayesian analyses further indicate that these introductions occurred during the past 300 years, with most of these events pre-dating the antibiotic era. Hence, the success of L2–Beijing in Africa is most likely due to its hypervirulence and high transmissibility rather than drug resistance.
Publisher Frontiers Media
ISSN/ISBN 2296-701X
edoc-URL https://edoc.unibas.ch/70632/
Full Text on edoc Available
Digital Object Identifier DOI 10.3389/fevo.2019.00112
ISI-Number WOS:000467434000001
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.325 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
13/05/2024